ABUS vs W
Arbutus Biopharma Corp (ABUS) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. W currently screens at market cap $10.77B.
Not investment advice. Open the ABUS and W stock pages for the full models.
Not investment advice.